~~<i id='4A20EBBBE9'><strike id='4A20EBBBE9'><tt id='4A20EBBBE9'><pre id='4A20EBBBE9'></pre></tt></strike></i>~~

Home» explore» entertainment

entertainment

author：fashion 2025-09-06 07:04:44 Page View：962

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tocagen's brain cancer gene therapy trial continues. Investors worry
Next article： Continuity nursing helped my family in our darkest PICU moments

focus

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Clinic falsely told dozens they had Alzheimer's, suits say

ShawnBlazsekwasoneofseveralpatientstoldincorrectlythathehadAlzheimer'sdiseasebyaclinicunderinvestiga

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

5:50InthisApril22,2022,filephoto,WashingtonstateGovernorJayInsleespeakspriortoPresidentJoeBidenatGre